Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma

被引：0
作者：
Yi Tao
Shiwei Jin
Dan Yang
Mengmeng Pan
Wanyan Ouyang
Yuanfang Liu
Yan Wang
Weiping Zhang
Jianqing Mi
机构：
[1] National Research Center for Translational Medicine at Shanghai,Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Department of Hematology
[2] Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Department of Hematology
[3] Lu Daopei Hospital,undefined
来源：
BMC Cancer | / 24卷
关键词：
Multiple myeloma; Autologous stem-cell transplantation; High-risk cytogenetics; Double hit; Minimal residual disease; Real-world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma
    Tao, Yi
    Jin, Shiwei
    Yang, Dan
    Pan, Mengmeng
    Ouyang, Wanyan
    Liu, Yuanfang
    Wang, Yan
    Zhang, Weiping
    Mi, Jianqing
    BMC CANCER, 2024, 24 (01)
  • [2] Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma
    Kang, Ka-Won
    Kim, Dae Sik
    Lee, Se Ryeon
    Heo, Mi Hwa
    Eom, Hyeon-Seok
    Jung, Jongheon
    Lee, Ji Hyun
    Kim, Sung-Hyun
    Koh, Youngil
    Min, Chang-Ki
    Lee, Seung Shin
    Lim, Sung-Nam
    Yhim, Ho-Young
    Lee, Myung-won
    Lee, Je-Jung
    Jung, Sung-Hoon
    Bang, Soo-Mee
    Kim, Kihyun
    BMC CANCER, 2025, 25 (01)
  • [3] Post Autologous Stem Cell Transplantation Maintenance for Multiple Myeloma Patients: Real World Experience and Results
    Byrne, Michael
    Dai, Yunfeng
    Nair, Jayan
    Chang, Myron
    Moreb, Jan S.
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 13 (05):
  • [4] Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study
    Seehaus, Cristian Maximiliano
    Schutz, Natalia
    Brulc, Erika
    Ferini, Gonzalo
    Arbelbide, Jorge
    Fantl, Dorotea
    Basquiera, Ana Lisa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S13 - S20
  • [5] Tandem Versus Single Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma in the Era of Novel Agents: A Real-World Study of China
    Dou, Xuelin
    Ren, Juan
    Li, Jiangtao
    Liu, Xiaodan
    Bao, Li
    Chen, Yuan
    Zhao, Peng
    Zhong, Yuping
    Peng, Nan
    Wen, Lei
    Cao, Leqing
    Liu, Yang
    Deng, Daoxing
    Wang, Fengrong
    Wang, Liru
    Liu, Hui
    Huang, Xiaojun
    Mo, Xiaodong
    Lu, Jin
    CANCER MEDICINE, 2025, 14 (01):
  • [6] Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma
    Pasvolsky, Oren
    Ghanem, Sassine
    Milton, Denai R.
    Masood, Adeel
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (12): : 757 - 762
  • [7] Profound MRD negativity rates after frontline tandem autologous-allogeneic stem cell transplantation followed by bortezomib maintenance in high-risk or young myeloma patients
    LeBlanc, Richard
    Ahmad, Imran
    Terra, Rafik
    Landais, Severine
    Nkoue, Celine
    Sebag, Michael
    Lemieux-Blanchard, Emilie
    Bambace, Nadia
    Bernard, Lea
    Cohen, Sandra
    Jean-Sebastien, Delisle
    Kiss, Thomas
    Lachance, Silvy
    Roy, Denis-Claude
    Sauvageau, Guy
    Roy, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10) : E41 - E42
  • [8] Tandem Autologous Stem Cell Transplantation Does Not Benefit fi t High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
    Venner, Christopher P.
    Duggan, Peter
    Song, Kevin
    Reece, Donna
    Sharma, Smriti
    Su, Jiandong
    Jimenez-Zepeda, Victor H.
    McCurdy, Arleigh
    Louzada, Martha
    Mian, Hira
    Sebag, Michael
    White, Darrell
    Stakiw, Julie
    Kotb, Rami
    Aslam, Muhammad
    Reiman, Anthony
    Gul, Engin
    Chu, Michael P.
    Bergstrom, Debra
    LeBlanc, Richard
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 889 - 901
  • [9] Using genomics to identify high-risk myeloma after autologous stem cell transplantation
    Shaughnessy, JD
    Barlogie, B
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (01) : 77 - 80
  • [10] Allogeneic Stem Cell Transplantation in Patients with High-Risk Multiple Myeloma: Utopia or Continuous Challenge in Aiming for Cure?
    Panayotis Kaloyannidis
    John Apostolidis
    Current Treatment Options in Oncology, 2021, 22
12345